Product Information
CLOBAZAM 20 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3902 per EA under NDC 68180015801. Its NADAC has been published 379 times since May 22, 2019.
FDA first approved this application on Dec 14, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180015801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA210545FDA Approved
12/14/2018
TE Code
AB
On Market Since
5/8/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 20 MG TABLET has been published 379 times since May 22, 2019, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3902 per EA |
|---|---|
| All-time high | $1.4581 (Jun 12, 2019) |
| All-time low | $0.3902 (Aug 19, 2026) |
| 52-week high | $0.5144 |
| 52-week low | $0.3902 |
| Median price | $0.6916 |
| Average price | $0.7089 |
| Largest weekly change | +78.0% (Aug 23, 2023) |
| Weeks tracked | 379 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOBAZAM 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 20 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3902 per EA (NDC 68180015801), effective Aug 19, 2026.
How has the price of CLOBAZAM 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 20 MG TABLET has declined 73.2%. It has been tracked across 379 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 20 MG TABLET?
Since May 22, 2019, the NADAC for CLOBAZAM 20 MG TABLET has ranged from a low of $0.3902 (Aug 19, 2026) to a high of $1.4581 (Jun 12, 2019), with a median of $0.6916 per EA.
Are there cheaper alternatives to CLOBAZAM 20 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOBAZAM 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOBAZAM 20 MG TABLET?
CLOBAZAM 20 MG TABLET (NDC 68180015801) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.